Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2016 Category: Drugs & Pharmacology Authors: Maria Teresa Donato Maria Jos é Gómez-Lechón Laia Tolosa Source Type: research

The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 20, 2016 Category: Drugs & Pharmacology Authors: Richard Arkwright Tri Minh Pham Jeffrey A. Zonder Q. Ping Dou Source Type: research

Drug discovery beyond the rule of 5 - Opportunities and challenges
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 9, 2016 Category: Drugs & Pharmacology Authors: Bradley C. Doak Jan Kihlberg Source Type: research

Advances in capillary electrophoresis and the implications for drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 9, 2016 Category: Drugs & Pharmacology Authors: Claire M. Ouimet Cara I. D ’amico Robert T. Kennedy Source Type: research

Drug discovery beyond the rule of 5 - Opportunities and challenges
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 9, 2016 Category: Drugs & Pharmacology Authors: Bradley C. Doak Jan Kihlberg Source Type: research

MicroRNA-targeted therapeutics for lung cancer treatment
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 29, 2016 Category: Drugs & Pharmacology Authors: Jing Xue Jiali Yang Meihui Luo William C. Cho Xiaoming Liu Source Type: research

Challenges for drug discovery and development in China
Volume 12, Issue 1, January 2017, Page 105-113 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 25, 2016 Category: Drugs & Pharmacology Authors: Kam Lun Hon Vivian W.Y Lee Source Type: research

Challenges for drug discovery and development in China
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 25, 2016 Category: Drugs & Pharmacology Authors: Kam Lun Hon Vivian W.Y Lee Source Type: research

The need for fundamental reforms in the pain research field to develop innovative drugs
Volume 12, Issue 1, January 2017, Page 39-46 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 23, 2016 Category: Drugs & Pharmacology Authors: Yukinori Nagakura Source Type: research

The need for fundamental reforms in the pain research field to develop innovative drugs
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 23, 2016 Category: Drugs & Pharmacology Authors: Yukinori Nagakura Source Type: research

Targeting of AMP-activated protein kinase: prospects for computer-aided drug design
Volume 12, Issue 1, January 2017, Page 47-59 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 14, 2016 Category: Drugs & Pharmacology Authors: Joungmok Kim Goowon Yang Joohun Ha Source Type: research

Targeting of AMP-activated protein kinase: prospects for computer-aided drug design
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 14, 2016 Category: Drugs & Pharmacology Authors: Joungmok Kim Goowon Yang Joohun Ha Source Type: research

Current challenges in drug discovery for tuberculosis
Volume 12, Issue 1, January 2017, Page 1-4 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 12, 2016 Category: Drugs & Pharmacology Authors: Anuradha Kumar Somsundaram Chettiar Tanya Parish Source Type: research

Current challenges in drug discovery for tuberculosis
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 12, 2016 Category: Drugs & Pharmacology Authors: Anuradha Kumar Somsundaram Chettiar Tanya Parish Source Type: research

The current status and future directions of hepatitis B antiviral drug discovery
Volume 12, Issue 1, January 2017, Page 5-15 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 11, 2016 Category: Drugs & Pharmacology Authors: Liudi Tang Qiong Zhao Shuo Wu Junjun Cheng Jinhong Chang Ju-Tao Guo Source Type: research

The current status and future directions of hepatitis B antiviral drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 11, 2016 Category: Drugs & Pharmacology Authors: Liudi Tang Qiong Zhao Shuo Wu Junjun Cheng Jinhong Chang Ju-Tao Guo Source Type: research

Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Volume 12, Issue 1, January 2017, Page 61-88 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 10, 2016 Category: Drugs & Pharmacology Authors: Claudiu T. Supuran Source Type: research

Advances in structure-based drug discovery of carbonic anhydrase inhibitors
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 10, 2016 Category: Drugs & Pharmacology Authors: Claudiu T. Supuran Source Type: research

New experimental models of the blood-brain barrier for CNS drug discovery
Volume 12, Issue 1, January 2017, Page 89-103 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 8, 2016 Category: Drugs & Pharmacology Authors: Mohammad A. Kaisar Ravi K. Sajja Shikha Prasad Vinay V. Abhyankar Taylor Liles Luca Cucullo Source Type: research

New experimental models of the blood-brain barrier for CNS drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 8, 2016 Category: Drugs & Pharmacology Authors: Mohammad A. Kaisar Ravi K. Sajja Shikha Prasad Vinay V. Abhyankar Taylor Liles Luca Cucullo Source Type: research

High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 4, 2016 Category: Drugs & Pharmacology Authors: Rumin Zhang Kenny Wong Source Type: research

Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 21, 2016 Category: Drugs & Pharmacology Authors: David R. Janero Ganesh A. Thakur Source Type: research

Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 18, 2016 Category: Drugs & Pharmacology Authors: Thelma S. Angeles Robert L. Hudkins Source Type: research

Discovery and optimization of peptide macrocycles
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 17, 2016 Category: Drugs & Pharmacology Authors: Andrew M. White David J. Craik Source Type: research

Structure-based discovery and binding site analysis of histamine receptor ligands
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 17, 2016 Category: Drugs & Pharmacology Authors: R óbert Kiss Gy örgy M. Keserű Source Type: research

Discovery and optimization of peptide macrocycles
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 17, 2016 Category: Drugs & Pharmacology Authors: Andrew M. White David J. Craik Source Type: research

Structure-based discovery and binding site analysis of histamine receptor ligands
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 17, 2016 Category: Drugs & Pharmacology Authors: R óbert Kiss Gy örgy M. Keserű Source Type: research

Approaches for targeting cancer stem cells drug resistance
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 14, 2016 Category: Drugs & Pharmacology Authors: Roberta Rosa Valentina D ’Amato Sabino De Placido Roberto Bianco Source Type: research

In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 12, 2016 Category: Drugs & Pharmacology Authors: Matthew H. Ung Frederick S. Varn Chao Cheng Source Type: research

Foreword
Volume 11, Issue 11, November 2016, Page 1027-1027 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 8, 2016 Category: Drugs & Pharmacology Authors: David Grech Source Type: research

The development of targeted new agents to improve the outcome for children with leukemia
Volume 11, Issue 11, November 2016, Page 1111-1122 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 27, 2016 Category: Drugs & Pharmacology Authors: Francisco Bautista Jasper Van der Lugt Pamela R. Kearns Francis J. Mussai C. Michel Zwaan Lucas Moreno Source Type: research

The development of targeted new agents to improve the outcome for children with leukemia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 27, 2016 Category: Drugs & Pharmacology Authors: Francisco Bautista Jasper Van der Lugt Pamela R. Kearns Francis J. Mussai C. Michel Zwaan Lucas Moreno Source Type: research

Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic
Volume 11, Issue 11, November 2016, Page 1071-1080 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 26, 2016 Category: Drugs & Pharmacology Authors: Angelo B. A. Laranjeira Sherry X. Yang Source Type: research

Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 26, 2016 Category: Drugs & Pharmacology Authors: Angelo B. A. Laranjeira Sherry X. Yang Source Type: research

Should network biology be used for drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 23, 2016 Category: Drugs & Pharmacology Authors: Francisco Mart ínez-Jiménez Marc A. Marti-Renom Source Type: research

The application of mass spectrometry to leukemia drug discovery
Volume 11, Issue 11, November 2016, Page 1029-1032 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 23, 2016 Category: Drugs & Pharmacology Authors: Gail J. Roboz John Roboz Source Type: research

Should network biology be used for drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 23, 2016 Category: Drugs & Pharmacology Authors: Francisco Mart ínez-Jiménez Marc A. Marti-Renom Source Type: research

The application of mass spectrometry to leukemia drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 23, 2016 Category: Drugs & Pharmacology Authors: Gail J. Roboz John Roboz Source Type: research

Centipede venoms as a source of drug leads
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 20, 2016 Category: Drugs & Pharmacology Authors: Eivind A.B. Undheim Ronald A. Jenner Glenn F. King Source Type: research

Toll-like receptors targeting technology for the treatment of lymphoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 20, 2016 Category: Drugs & Pharmacology Authors: Maria Batool Muhammad Ayaz Anwar Sangdun Choi Source Type: research

Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 20, 2016 Category: Drugs & Pharmacology Authors: Federica Barbieri Adriana Bajetto Stefano Thellung Roberto W ürth Tullio Florio Source Type: research